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Abstract
Background: Amnion-derived stem cells have been proposed for cell replacement therapy and tissue regeneration.
An easily accessible cell source, the placenta, allows us to potentially establish a bio-bank of cells for immunotype
matched clinical applications. Several xeno-free (XF) cryopreservation media are currently available for pluripotent stem
cells, however, these media have not yet been evaluated for the cryopreservation of amnion-derived stem cells.
Methods: Human amniotic epithelial cells were collected using standard protocols, and stored at −160 °C in one of
five commercially available media. Cells frozen in standard media containing fetal bovine serum served as controls.
Cells were then thawed, and evaluated for viability, mitochondrial membrane stability, and senescence status.
Quantitative real time PCR was utilized to assess for expression of stem cell genes, and flow cytometry was used to
identify the stem cell surface markers.
Results: Cell recovery and repopulation assays indicated no significant difference between XF media versus standard
cryopreservation medium. In addition, no impact was observed on the senescence status, the cytostructural or
mitochondrial morphology between the tested cryopreservation media. Differences were observed on the expression
of stem cell marker genes (OCT4, SOX2, and NANOG) and a cell surface marker (TRA1-60) following cryopreservation in
different chemically defined XF media, however, these were not statistically significant.
Conclusions: Xeno-free cryopreservation of human amnion-derived stem cells is feasible and can be standardized to
establish a bio-bank with human amnion-derived stem cells for future clinical application. Optimization of this media
may allow for improved preservation of stem cell-like characteristics.
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Background
Over the last decade, there has been a growing interest
in the placenta as a rich source of stem cells [1, 2]
without the limitations and ethical concerns associated
with the use of other pluripotent stem cell sources.
Human amniotic epithelial cells (hAECs) are derived
from the epiblast and retain stem cell-like characteristics
[3, 4]. Although pluripotency of a single amniotic epithelial
(AE) cell has not yet been identified, under appropriate
culture conditions hAECs exhibit the capability of
differentiating into all three germ layers [5, 6]. A variety
of preclinical studies have already shown the promising
therapeutic value of hAECs [7–12]. The large volume
of available placental tissue in conjunction with limited
ethical concerns of the cell source, suggests the possibility
of a biobank system to provide immunotype-matched
hAECs for future clinical applications [13].
It is essential to establish a reliable and reproducible
cryopreservation protocol for a clinically applicable
biobanking system. Ideally, the banking system would be
networked among multiple procurement centers to pro-
vide all needed immunotypes [14]. In order to establish
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the multicenter network, the cryopreservation protocol
needs to be standardized to maintain homogeneity of
banked cells, and allow them to maintain their stem cell-
like characteristics. This concept has already been applied
to the cryopreservation of hematopoietic stem cells for
clinical applications [12, 15]. The cryopreservation proto-
cols for other emerging progenitor cell populations have
also been demonstrated in several studies [16–19], how-
ever, it has not been demonstrated for hAECs.
Conventional cryopreservation media contains fetal
bovine serum (FBS), a mixture of growth factors, cyto-
kines and undefined substances which includes bovine
exosomes [20–22]. These undefined substances, and the
concern for transmission of zoonotic disease, prohibit the
use of FBS when establishing a standardized cryopreserva-
tion protocol for clinical use in humans. Several serum-
free cryopreservation media and methods have been de-
veloped and distributed on the market as good manufac-
turing practice (GMP)-compliant or GMP-amenable
products [15, 23–25]. The aim of this study is to demon-
strate the feasibility in establishing a standardized cryo-
preservation protocol with commercially available, xeno-
free, chemically defined cryopreservation medium for fu-
ture clinical therapy.
Methods
Isolation and culture of human amniotic epithelial cells
Human placentae were obtained from the Los Angeles
County and University of Southern California Medical
Center. All placental samples were de-identified and
otherwise considered medical waste. The tissue collection
was approved as non-human subject (45 CFR 46.102(f)),
which does not require consent, by the University of
Southern California Health Sciences institutional review
board (IRB: HS-11-00206). Only those from healthy
mothers undergoing uncomplicated elective caesarean
deliveries were utilized. Any patient testing positive for
human immunodeficiency virus, hepatitis B virus, hepa-
titis C virus, tuberculosis, chlamydia trachomatis, neisseria
gonorrhoeae, syphilis or any placenta showing any macro-
scopic abnormality were excluded. hAECs were enzymati-
cally isolated from the amniotic membrane as previously
described [26].
In brief, the amnion layer was mechanically separated
from the chorion layer and washed several times with
phosphate-buffered saline without calcium and magne-
sium (PBS) to remove blood. To dissociate AE cells, the
amniotic membrane was incubated at 37 °C with 0.05 %
trypsin containing 0.53 mM EDTA4Na (Life Technolo-
gies, Grand Island, NY, USA). Digesta from the first 10 mi-
nutes of the trypsin digestion were discarded to exclude
debris. Cells from the second and third 40-minute digests
were pooled and washed three times with PBS. The viabil-
ity of the AE cells was determined by exclusion of trypan
blue dye and counted with a hemocytometer. Cells were
cultured at 65 × 103/cm2 in high-glucose DMEM with
10 % FBS supplemented 10 ng/ml recombinant human
epidermal growth factor (AF-100-15, PEPROTECH, Rocky
Hill, NJ, USA). Unattached cells and debris were removed
after 24 h. One million cells were used immediately for
characterization as a day-0 sample. After culturing for
5 days, cells were dissociated with trypsin and cryopre-
served as described below.
Cryopreservation and thawing procedures
Five commercial xeno-free cryopreservation media were
examined: CryoStor CS10, CryoStor CS5 (BioLife
Solutions, Bothell, WA, USA), STEM-CELLBANKER
(amsbio, Cambridge, MA, USA), CryoStem (Stem-
gent, Lexington, MA, USA), and Synth-a-Freeze (Life
Technologies) (Table 1). Standard cryomedium (FBS-10:
90 % FBS + 10 % dimethyl sulfoxide (DMSO)) was used
as a control. Cells were washed twice with PBS and resus-
pended at a concentration of 1 × 106 cells/ml in each ice-
cooled cryomedium, and transferred to cryotube vials
(Nunc Cryotube, Thermo Scientific, Waltham, MA, USA)
samples were cooled in a standard freezing container (Nal-
gene, Thermo Scientific) to −80 °C at −1 °C/min. After
24 h, samples were transferred to a liquid nitrogen tank
and cryopreserved for 2 weeks at the vapor phase of liquid
nitrogen (−151 to approximately −172 °C). To thaw cryo-
preserved samples, cryotubes were placed in a 37 °C water
bath for rapid thawing until almost no ice was detectable.
Cell viability was examined immediately after thawing,
using the trypan blue exclusion method. Cells were
washed once with culture medium and cultured in
triplicate on 6-well culture plates, 4-chamber slides
for chemifluorescence analyses, or 96-well plates for
(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) assay at 37 °C, 5 % CO2 incubator.
Determination of cell viability and recovery
The impact of cryomedia on the cell repopulation cell
viability was tested by MTT assay. Briefly, the AE cells
(104 cells/well) were plated into flat bottom 96-well tissue
culture plates. After 48 h, 10 ul MTT solution (Bio-
tium, Hayward, CA, USA) was added to 100 ul of medium
in each well. The plates were incubated at 37 °C for 2 h.
Table 1 Tested cryopreservation media
Medium Brand name Provider Cat number
1 CryoStor CS10 BioLife Solutions 210102
2 CryoStor CS5 BioLife Solutions 205102
3 STEM-CELLBANKER amsbio 11897
4 CryoStem Stemgent 01-0013-51
5 Synth-a-Freeze Life Technologies A12542-01
Commercially available xeno-free cryopreservation media used for this study
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The 570 nm absorbance and 630 nm background signal
was measured and subsequently subtracted from the sig-
nal absorbance to calculate a normalized absorbance
value. Cell repopulation was defined by the MTT assay as
the amount of viable cells repopulated following cryo-
preservation, and cell recovery was defined as the percent-
age of viable cells following cryopreservation as compared
to the number of pre-freeze viable cells.
Chemifluorescence analysis
To examine the effects of freezing on mitochondrial
membrane stability, MitoTracker Red CMXRos (Life
Technologies) was used to visualize the mitochondria of
hAECs following the manufacturer’s instructions. Briefly,
after thawing, hAECs were cultured on a permanox 4-
chamber slide (Lab-Tek, Thermo Fisher Scientific) for
2 days. When cultures reached 50 % confluency, hAECs
were permeabilized by immersion in 0.1 % Triton X-100
in PBS for 10 minutes and incubated in AE media
containing 2 nM of Mitotracker Red CMXRos for 25 -
minutes. Cells were then washed twice with PBS and
fixed in 2 % (w/v) paraformaldehyde in PBS. To examine
the cell membrane and cytoskeleton integrity, cells were
simultaneously stained with Alexa Fluor 488 conjugated
phalloidin (1:40, Life Technologies). 4′,6-diamidino-2-
phenylindole (DAPI) containing mountant (ProLong
Gold Antifade Mountant, Life Technologies) was used to
seal the slides and counterstain nuclei. The stained
hAEC images were captured using either a LSM 5
Exciter confocal laser-scanning microscope or an Axiovert
200 fluorescence/live cell imaging microscope (ZEISS,
Thornwood, NY, USA). The CMXRos fluorescence inten-
sity was analyzed with a scientific image-analysis program,
ImageJ. The chemifluorescent images were split to three
RGB channels, with the blue channel images used to
count the number of nuclei and the red channel images
for quantification of the integrated density of CMXRos.
Real-time quantitative PCR
Total RNA was isolated utilizing the RNeasy Plus Mini Kit
(Qiagen, Valencia, CA, USA) following the manufacturer’s
protocol and the cDNA was synthesized from 1 μg RNA
using qScript™ cDNA SuperMix (Quanta Biosciences, Gai-
thersburg, MD, USA). Quantitative real-time PCR (qRT-
PCR) was carried out using the ViiA™ 7 Real-Time PCR
System (Life Technologies) with PerfeCTa SYBR Green
SuperMix (Low ROX) master mix (Quanta Biosciences).
All reactions were carried out on the same plate in dupli-
cate with amplification of the target genes: POU domain
class 5 transcription factor 1 (OCT4), SRY (sex determin-
ing region Y)-box 2 (SOX2), Nanog homeobox (NANOG),
alpha-L-iduronidase (IDUA), branched chain keto acid de-
hydrogenase E1, alpha polypeptide (BCKDHa), and the
endogenous housekeeping gene, peptidylprolyl isomerase
A (PPIA). Relative quantitative evaluation of target genes
was determined by comparative cycle threshold (Ct)
method (2–(delta)(delta)Ct method). The delta-Ct value
from the FBS-10 group was used as the biological refer-
ence value. Primer sequences were hOCT4A-F 5′-ctt cgc
aag ccc tca ttt c-3′, hOCT4A-R 5′-gag aag gcg aaa tcc gaa
g-3′, Sox2-F 5′-tgc tgc ctc ttt aag act agg ac-3′, Sox2-R 5′-
cct ggg gct caa act tct ct-3′, NANOG-F 5′-aga tgc ctc aca
cgg aga ct-3′, NANOG-R 5′-ttt gcg aca ctc ttc tct gc-3′,
IDUA-F 5′-tgg agg agc aca ggc ttc-3′, IDUA-R 5′-cca gct
gag gac gta ctg gt-3′, BCKDHa-F 5′- gac ctg gtg ttt ggc
cag ta-3′, BCKDHa-R 5′- tgg gcc atg aat agt tcc ag-3′,
PPIA-F 5′-cct aaa gca tac ggg tcc tg-3′, PPIA-R 5′-ttt cac
ttt gcc aaa cac ca-3′.
Flow cytometric analysis
Samples were prepared with 1 × 106 cells in 100 ul PBS
with 1 % FBS and incubated for 40 minutes at 4 °C with
the following antibodies; fluorescein isothiocyanate
(FITC) conjugated Anti-TRA-1-60 antibody (mouse
IgM, FCMAB115F, Millipore, Billerica, MA, USA), FITC
conjugated Anti-Human Embryonic Stem Cell Antigen-
1 (HESCA-1) antibody (mouse IgM, FCMAB111F, Milli-
pore) and FITC conjugated isotype mouse IgM (clo-
ne:11E10, eBioscience, San Diego, CA, USA). After
incubation, cells were washed and analyzed with the BD
LSR II Analyzer and BD FACSDiVaTM Software Version
6.1 (BD Biosciences, San Jose, CA, USA), or FlowJo 10.0.8
data analysis software (FLOWJO LLC, Ashland, OR,
USA).
Senescence detection assay
Cryopreserved hAECs were tested for senescence with the
use of the cellular senescence detection kit (Biovision,
Mountain View, CA, USA), which histochemically detects
senescence-associated lysosomal β-galactosidase (SA-β-
Gal) expression. After 2 weeks of cryopreservation in
cryopreservation media, hAEC were maintained in the
standard medium at 37 °C in 5 % CO2 for 21 days with
three passages. Prior to the senescence detection assay,
cells were seeded in 12-well plates at a density of 105
cells/well. The hAECs were subsequently fixed and stained
for 18 h at 37 °C according to manufacturer’s instructions.
Five phase contrast images were randomly acquired from
one well at × 10 magnification. The number of SA-β-Gal
positive cells were counted and the ratio of senescent
cells/total number of nuclear was calculated.
Statistical analysis
Results are expressed as mean ± standard error of the
mean (SEM). To minimize the influence of the variability
of clinical samples, we normalized the data with FBS-10
data for each case and expressed as relative values.
Statistical analysis was performed with Prism 5.0a
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(GraphPad Software, San Diego, CA, USA). Experimental
and control groups were compared with paired or
unpaired one-way analysis of variance (ANOVA) with
Bonferroni post hoc analysis and Dunnett’s multiple
comparison test. A value of p <0.05 was considered
statistically significant.
Results
Impact of serum and xeno-free cryopreservation media
on human amniotic epithelial cells
A total of 18 human placentae were obtained to isolate
hAECs. Two of them were excluded from the study due
to the low cell attachment at the time of initial plating.
In the remaining 16 cases, more than 70 % of isolated
the hAECs attached to uncoated cell culture-grade
dishes and demonstrated the typical cobblestone shape
morphology under epidermal growth factor (EGF) sup-
plementation as described previously [5]. The hAECs
proliferated and reached about 80 % confluence on day
5 after isolation. Five commercial xeno-free cryomedia,
proposed for stem cell cryopreservation, were selected;
CryoStor CS10, CryoStor CS5 (BioLife), STEM-
CELLBANKER (amsbio), CryoStem (Stemgent), and
Synth-a-Freeze (Life Technologies) and were compared
with a standard cryomedium (FBS-10: 90 % FBS + 10 %
DMSO). All of these cryomedia contain 5 to approxi-
mately 15 % DMSO. The impacts of each xeno-free
cryopreservation medium on post-thaw cell recovery
and cell repopulation were evaluated (n = 12). The abso-
lute number of viable cells in each tube was directly
counted after cryopreservation by the trypan blue exclu-
sion method utilizing a hemocytometer (Fig. 1a). The
cell repopulation capability was evaluated 48 h after
thawing by using a quantitative colorimetric MTT assay
(Fig. 1b). After cryopreservation, no significant differences
were observed in either cell viability or cell repopulation
capability between the different cryopreservation media.
Confocal microscopic analysis of cell membrane integrity
and mitochondria damage after cryopreservation
Confocal microscopic fluorescent images illustrate the
actin cytoskeleton and mitochondria quality after cryo-
preservation with each tested medium (Fig. 2a). Cells iso-
lated from eight different placentae were examined. Two
days after thawing, cells were stained with Mitotracker
Red Chloromethyl-X-rosamine (CMXRos) and counter-
stained with Alexa488 conjugated phalloidin and DAPI.
CMXRos is a lipophilic cationic fluorescent dye that is
concentrated inside mitochondria. As this localization is
dependent on the mitochondrial membrane potential, the
fluorescence intensity represents the overall mitochondrial
membrane potential of the cells. We have evaluated the
CMXRos fluorescence intensity in each cryopreservation
media exposed sample using a scientific image-analysis
program, ImageJ (n = 8). The chemifluorescent images
were split into three RGB channels; blue channel images
were used to count the number of nuclei and red channel
images were used to measure the integrated density of
CMXRos. Each integrated density value was normalized
by the number of nuclei to obtain an arbitrary number of
CMXRos intensity per cell. The average and SEM values
were plotted as relative to the value of FBS standard
cryopreserved samples (Fig. 2b). CMXRos fluorescence
intensity per cell was slightly higher in the CELL
BANKER-treated cells, however these differences were
not statistically significantindicating that all tested cryo-
media preserved the mitochondrial membrane potential
of these cells. There was no observable difference in cyto-
plasmic loss or mitochondrial clustering in any of the
groups. Most cells revealed typical epithelial cell morph-
ology on the uncoated permanox surface within a size of
Fig. 1 Comparison of cell recovery and repopulation capability. Cell
viability was analyzed immediately after thawing, using the trypan
blue exclusion method (n = 12). The mean value with standard error
of the mean (SEM) of each group is presented (a). Cell repopulation
capability after cryopreservation was evaluated 48 h after thawing,
using the MTT assay (n = 12). The absorbance (A570–A630) values
were normalized to unfrozen (Live) sample values. The percentage
ratio with SEM of each group is presented (b)
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up to 30 μm. Some cells were small and round in shape
(about 10 μm in diameter). Based on previously reported
observations the small cells were expected to be
undifferentiated or immature cells, which may retain
stem cell-like characteristics [5]. There were no significant
differences between the samples in the number of small
cell populations (Fig. 2c).
Stem cell characteristics of hAEC after preservation
The expression of the stem cell marker genes (n = 12;
OCT4, SOX2 and NANOG) and the stem cell surface
markers (n = 6; TRA1-60 and HESCA-1) was examined
after cryopreservation. Cells cryopreserved with STEM-
CELLBANKER best preserved expression of the stem cell
marker genes (Fig. 3a). Significant differences were not
detected between groups using one-way ANOVA; OCT4
(p = 0.4513), SOX2 (p = 0.6686), and NANOG (p = 0.2088).
However, the relative expression of all stem cell marker
genes in cells cryopreserved in STEM-CELLBANKER and
CryoStem were increased as compared to the other three
cryomedia. No differences were detected in expression of
the functional enzyme genes, IDUA and BCKDHa, in cells
preserved in the different media (Fig. 3b).
Flow cytometric analyses were performed to examine
the embryonic stem cell surface markers, TRA1-60 and
HESCA-1 (n = 6). The forward scatter (FSC) and side
scatter (SSC) gating revealed the hAEC to be a single
cell population in cell size and complexity. Subsequently,
Fig. 2 Cell and mitochondria morphology. Cell and mitochondria morphology was evaluated by chemifluorescence 2 days after thawing (n=8).
The cells were stained with Alexa Fluor 488-phalloidin (green) to visualize actin filaments and MitoTracker Red (LifeTech, M7512) to evaluate
mitochondria membrane stability (a). We used 4′,6-diamidino-2-phenylindole to counterstain the cell nuclei (blue). Scale bars represent 20 μm.
CMXRos fluorescence intensity was measured with ImageJ and the average and standard error of the mean (SEM) were plotted as relative to the
value of FBS control group (b). Numbers of small round cells were counted with ImageJ software and mean number of cells per mm2 of each
group is presented with SEM (c).
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the FSC-H and FSC-A gating was applied to identify
single cell events. The ratio of stem cell surface marker
positive cells was determined with the FITC intensity
and FSC-A gating (Fig. 4a). Overall both stem cell
markers were expressed in approximately 5 % of cryo-
preserved hAEC, however, this expression was varied in
each placenta. In order to demonstrate the impact of
different cryopreservation media, the relative value of
each group as compared to FBS samples was calculated
and analyzed with one-way ANOVA using Dunnet’s
multiple comparison test (n = 6). Although STEM-CELL
BANKER and Synth-a Freeze cryomedia relatively
preserved more tumor rejection antigen (TRA)1–60-
positive cells than other cryomedia, these differences
were not significant (p = 0.2596). Nor was there a differ-
ence between the groups in the number of human
embryonic stem cell antigen-1 (HESCA-1)-positive cells
(p = 0.3680) (Fig. 4b).
Senescence-associated lysosomal β-galactosidase activity
in crypreserved hAECs
The ratio of senescence-associated lysosomal β-
galactosidase (SA-β-Gal)-positive cells was not significantly
different between the tested cryomedia (p = 0.7677, one-
way ANOVA). In the FBS/DMSO control group 37.15 ±
3.601 % of hAEC were positive for SA-β-Gal, whereas
other groups with xeno-free media preserved the following
results were observed; CryoStor CS10: 47.22 ± 6.497 %,
Fig. 3 Stem cell marker genes expression. Real-time quantitative PCR analyses reveal relative stem cell marker gene (a) and functional enzyme
gene (b) expression after cryopreservation (n = 12). Levels of gene expression were plotted against conventional FBS/10 % dimethyl sulfoxide
(DMSO) cryopreservation medium
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CryoStor CS5: 49.18 ± 5.081 %, STEM-CELL BANKER:
49.15 ± 8.118 %, CryoStem: 50.00 ± 6.951 %, and Synth-a-
Freeze: 48.11 ± 6.588 % (Fig. 5). Consistent with the cell re-
covery and repopulation capability data, no impact of
xeno-free cryomedia was observed and there was no sig-
nificant difference between the tested xeno-free cryomedia.
Discussion
The establishment of an efficient and simple cryopreser-
vation protocol is crucial for a consistent supply of a
sufficient number of cells for future clinical applications,
as human pluripotent stem cells are known to be highly
susceptible to freeze-thaw damage. Vitrification techniques
have been used to improve the recovery of stem cells; how-
ever, the procedure is cumbersome and the high osmolality
of the cryopreservation media are highly toxic to the cells.
In this current study we have successfully applied commer-
cially available serum-free and xeno-free chemically defined
media to cryopreserve hAECs with a simple slow freezing
protocol. Conventional slow freezing media contain 5–20 %
DMSO and/or glycerol as cryoprotectants to prevent for-
mation of micro ice crystals, which impair cytoplasmic
structures including the cytoskeleton fibers [27, 28] and
the mitochondrial membrane [29–32]. Traditional freezing
medium also contains high concentrations of FBS, which
increases not only the risks of undesired immunological
Fig. 4 Stem cell surface marker expression. Representative pseudo-color density plots demonstrate gating strategy in flow cytometric analyses (a).
The relative value of tumor rejection antigen (TRA) 1–60 and human embryonic stem cell antigen-1 (HESCA-1)-positive cells to control samples
was plotted for the comparison of each xeno-free cryopreservation medium (b). AE amniotic epithelial, SSC side scatter, FSC forward scatter
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reactions but also zoonosis. Over the last decade alterna-
tive cryoprotective substances, which avoid these potential
problems have been developed, including disaccharide tre-
halose [33], oligosaccharide [34], and sericin [35]. These
allow for the cryopreservation and recovery of human
pluripotent stem cells without the loss of stem cell charac-
teristics [36]. Among these newly developed cryopreserva-
tion media, we tested five different commercially available
xeno-free chemically defined freezing media with a simple
in-suspension slow freezing protocol. All five freezing
media successfully cryopreserved human AE cells, and
allowed for their recovery. We were able to visualize the
linear polymer microfilaments, filamentous actin (F-actin),
with fluorescein-conjugated phalloidin, and no differences
were seen in the cytoskeletal morphology between hAECs
preserved in the different media. Similarly, following cell
staining with Mitotracker Red CMWRos, no differences
were seen between the cryomedia in the effect on mito-
chondrial membrane stability.
Differences were observed between tested media in the
preservation of both stem cell surface antigens and marker
genes. Of the commercially available cryopreservation
media tested, STEM CELL BANKER, appeared superior in
preserving the pluripotent stem cell marker genes; OCT4,
SOX2 and NANOG, and the stem cell surface markers
TRA1–60, however, this difference was not statistically
significant. Our study further supports existing data show-
ing the high cryopreservation efficiency of STEM CELL
BANKER cryomedia, previously demonstrated in mouse
induced pluripotent stem (iPS) cells [17], human iPS
cells [37, 38], mesenchymal stem cells [39], and primary
hepatocytes [40]. None of these studies compared these
media with other commercially available xeno-free
chemically defined freezing media or examined the effect
of these media on transcription and expression of stem
cell markers.
To the best of our knowledge, this is the first report to
demonstrate that STEM CELL BANKER cryomedia
Fig. 5 Post-cryopreservation senescence marker activity. Cryopreserved human amniotic epithelial cells were cultured for 21 days and the influence
of cryopreservation was evaluated by senescence-associated-beta-galactosidase (SA-βgal) activity, which is detectable in the cytoplasmic blue color
staining (a). The ratio of SA-β-Gal-positive cells was calculated and demonstrated as mean ± standard error of the mean (b)
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preserves stem cell populations of primary hAECs and,
when compared to other commercially available media,
allows for improved maintenance of stem cell character-
istics. Scanning electron microscopy would be useful in
order to further analyze membrane integrity and struc-
tural alterations. It is unlikely however, that the impact
on membrane integrity and structural alterations would
influence only stem cell characteristics and not cell
recovery and viability. It has been disclosed that STEM
CELLBANKER contains 10 % DMSO, glucose, and high
molecular weight polymer in PBS [37]. Due to the
proprietary information on the exact contents of the
media, further mechanism analysis on the preservation
of stem cell characteristics is limited.
Two major advantages of using commercially available
cryopreservation media are the availability and the quality.
Both parameters are essential to establish a standardizing
protocol, which can be applied to isolate hAECs in a wide
range of otherwise non-standard conditions. Unlike other
stem cells, amnion-derived stem cells can be isolated from
human placentae, which are normally discarded as med-
ical waste and therefore readily available in most coun-
tries. To establish an efficient biobank system, networking
the cell supply with the standardized isolation/cryopreser-
vation protocol is essential. A quality-controlled product
is currently most suitable for this purpose. As mentioned
above the STEM CELLBANKER media has already been
utilized with various human cell types currently in consid-
eration for clinical applications and thus, there are
accumulating safety data for its use in clinical trials. In
addition to providing consistent materials for use in any
standardized protocol, this will allow for a more stream-
lined clearance of regulatory hurdles for its use with
alternative cell sources. Taken together, commercially
available cryopreservation media are good candidates
for further investigation when establishing standardized
cryopreservation protocols.
Conclusions
In conclusion, the current study demonstrates that all
tested commercially available xeno-free cryopreserva-
tion media successfully cryopreserved human amniotic
epithelial cells without losing post-thaw cell viability
and repopulation ability. Variable results were observed
between the tested cryopreservation media in the pres-
ervation of stem cell characteristics of human amnion-
derived stem cells. Although STEM CELLBANKER
appeared to best maintain the stem cell markers in
hAECs, the differences were not statistically significant.
A larger sample size might better discern this. These
data indicate that establishing a standardized cryo-
preservation protocol using commercially available
xeno-free media is feasible for amnion-derived stem
cell banking.
Abbreviations
AE: amniotic epithelial; ANOVA: analysis of variance; BCKDHa: branched chain
keto acid dehydrogenase E1, alpha polypeptide; Ct: cycle threshold;
DAPI: 4′,6-diamidino-2-phenylindole; DMEM: Dulbecco’s modified Eagle’s
medium; DMSO: dimethyl sulfoxide; ES: embryonic stem; FBS: fetal bovine
serum; FITC: fluorescein isothiocyanate; FSC: forward scatter; GMP: good
manufacturing practice; hAEC: human amniotic epithelial cell; IDUA: alpha-L-
iduronidase; iPS: induced pluripotent stem; MTT: (3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide; NANOG: nanog homeobox; OCT-
4: POU domain, class 5, transcription factor 1; PBS: phosphate-buffered saline;
PPIA: peptidylprolyl isomerase A; SA-β-Gal: senescence-associated lysosomal
β-galactosidase; SEM: standard error of the mean; SOX-2: SRY- sex
determining region Y-box 2; SSC: side scatter; SSEA: stage-specific embryonic
antigen; TRA: tumor rejection antigen.
Competing interests
The author, TM, owns stock in Stemnion, Inc. The authors have received no
payment for the preparation of this manuscript and state no other financial
and non-financial conflict of interests.
Authors’ contributions
WW participated in design of the studies, carried out the cell culture and
FACS and MTT assays. EZ participated in conducting chemifluorescence
staining. AG and IG contributed to cell isolation and the senescence assay.
BG contributed to the collection of placentae and preparing of the
manuscript. TM participated in the design of the studies and interpretation
of data, and prepared the manuscript. All authors have been involved in
revising the manuscript and approved the final manuscript.
Acknowledgements
WW and EZ were supported by the USC Science, Technology And Research
(STAR) program. The authors appreciate Dr. Roberta Diaz Brinton and Ms.
Glendy Ramirez-De La Cruz for directing and coordinating the program. The
authors would like to thank Ms. Lora Barsky and Ms. Bernadette Masinsin for
their excellent technical assistance on flow cytometric analysis. This work was
supported by California Institute for Regenerative Medicine (CIRM) grant
TR3-05488 (TM).
Author details
1Department of Biochemistry and Molecular Biology, Keck School of
Medicine, University of Southern California, Los Angeles, CA, USA.
2Department of Obstetrics and Gynecology, Keck School of Medicine,
University of Southern California, Los Angeles, CA, USA. 3Eli and Edythe
Broad Center for Regenerative Medicine and Stem Cell Research at USC, Keck
School of Medicine, University of Southern California, Los Angeles, CA, USA.
Received: 12 March 2015 Revised: 20 March 2015
Accepted: 4 December 2015
References
1. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring H-J, Evangelista M, et al.
Concise review: isolation and characterization of cells from human term
placenta: outcome of the first international Workshop on Placenta Derived
Stem Cells. Stem Cells. 2008;26:300–11.
2. Ilancheran S, Moodley Y, Manuelpillai U. Human Fetal Membranes: A Source
of Stem Cells for Tissue Regeneration and Repair? Placenta. 2009;30:2–10.
3. Miki T. Amnion-derived stem cells: in quest of clinical applications. Stem Cell
Res Ther. 2011;2:25.
4. Miki T, Grubbs B. Therapeutic potential of placenta-derived stem cells for liver
diseases: Current status and perspectives. J Obstet Gynaecol Res. 2014;40:360–8.
5. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of
amniotic epithelial cells. Stem Cells. 2005;23:1549–59.
6. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem
cells derived from human fetal membranes display multilineage
differentiation potential. Biol Reprod. 2007;77:577–88.
7. Manuelpillai U, Lourensz D, Vaghjiani V, Tchongue J, Lacey D, Tee J-Y, et al.
Human amniotic epithelial cell transplantation induces markers of
alternative macrophage activation and reduces established hepatic fibrosis.
PLoS One. 2012;7, e38631.
Miki et al. Stem Cell Research & Therapy  (2016) 7:8 Page 9 of 10
8. Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, et al.
Placental stem cell correction of murine intermediate maple syrup urine
disease. Hepatology. 2013;57:1017–23.
9. Liu YH, Vaghjiani V, Tee JY, To K, Cui P, Oh DY, et al. Amniotic epithelial cells
from the human placenta potently suppress a mouse model of multiple
sclerosis. PLoS One. 2012;7, e35758.
10. Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al.
Anti-inflammatory effects of adult stem cells in sustained lung injury: a
comparative study. PLoS One. 2013;8, e69299.
11. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic
membrane/amnion-derived cells for regeneration of various tissues.
J Pharmacol Sci. 2007;105:215–28.
12. Parolini O, Alviano F, Bergwerf I, Boraschi D, De Bari C, De Waele P, et al.
Toward cell therapy using placenta-derived cells: disease mechanisms, cell
biology, preclinical studies, and regulatory aspects at the round table. Stem
Cells Dev. 2010;19:143–54.
13. Strom SC, Skvorak K, Gramignoli R, Marongiu F, Miki T. Translation of
amnion stem cells to the clinic. Stem Cells Dev. 2013;22 Suppl 1:96–102.
14. Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells.
Nat Biotechnol. 2008;26:739–40.
15. Massie I, Selden C, Hodgson H, Fuller B, Gibbons S, Morris GJ. GMP
Cryopreservation of large volumes of cells for regenerative medicine: active
control of the freezing process. Tissue Eng Part C Methods. 2014;20:1–46.
16. Roy S, Arora S, Kumari P, Ta M. A simple and serum-free protocol for
cryopreservation of human umbilical cord as source of Wharton’s jelly
mesenchymal stem cells. Cryobiology. 2014;68:467–72.
17. Miyamoto Y, Noguchi H, Yukawa H, Oishi K, Matsushita K, Iwata H, et al.
Cryopreservation of induced pluripotent stem cells. Cell Med. 2012;3:89–95.
18. Cohen RI, Thompson ML, Schryver B, Ehrhardt RO. Standardized
cryopreservation of pluripotent stem cells. Curr Protoc Stem Cell Biol.
2014;28:Unit 1C.14.
19. Jorns C, Ellis EC, Nowak G, Fischler B, Nemeth A, Strom SC, et al. Hepatocyte
transplantation for inherited metabolic diseases of the liver. J Intern Med.
2012;272:201–23.
20. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update.
2007;13:591–605.
21. Li Y, Tan J-C, Li L-S. Comparison of three methods for cryopreservation of
human embryonic stem cells. Fertil Steril. 2010;93:999–1005.
22. Karlsson JOM, Toner M. Long-term storage of tissues by cryopreservation:
Critical issues. Biomaterials. 1996;17:243–56.
23. Mitry RR, Lehec SC, Hughes RD. Cryopreservation of human hepatocytes for
clinical use. Methods Mol Biol. 2010;640:107–13.
24. Polchow B, Kebbel K, Schmiedeknecht G, Reichardt A, Henrich W, Hetzer R,
et al. Cryopreservation of human vascular umbilical cord cells under good
manufacturing practice conditions for future cell banks. J Transl Med.
2012;10:98.
25. Stacy GN, Masters JR. Cryopreservation and banking of mammalian cell
lines. Nat Protoc. 2008;3:1981–89.
26. Miki T, Marongiu F, Dorko K, Ellis ECS, Strom SC. Isolation of amniotic
epithelial stem cells. Curr Protoc Stem Cell Biol. 2010;Chapter 1:Unit 1E.3.
27. Hall SM, Evans J, Haworth SG. Influence of cold preservation on the
cytoskeleton of cultured pulmonary arterial endothelial cells. Am J Respir
Cell Mol Biol. 1993;9:106–14.
28. Ahn HJ, Sohn IP, Kwon HC, Jo DH, Park YD, Min CK. Characteristics of the
cell membrane fluidity, actin fibers, and mitochondrial dysfunctions of
frozen-thawed two-cell mouse embryos. Mol Reprod Dev. 2002;61:466–76.
29. Wilson JM, Caceci T, Potter GD, Kraemer DC. Ultrastructure of cryopreserved
horse embryos. J Reprod Fertil Suppl. 1987;35:405–17.
30. Sammut IA, Thorniley MS, Simpkin S, Fuller BJ, Bates TE, Green CJ.
Impairment of hepatic mitochondrial respiratory function following storage
and orthotopic transplantation of rat livers. Cryobiology. 1998;36:49–60.
31. Ogier de Baulny B, Labbé C, Maisse G. Membrane integrity, mitochondrial
activity, ATP content, and motility of the European catfish (Silurus glanis)
testicular spermatozoa after freezing with different cryoprotectants.
Cryobiology. 1999;39:177–84.
32. Stéphenne X, Najimi M, Ngoc DK, Smets F, Hue L, Guigas B, et al.
Cryopreservation of human hepatocytes alters the mitochondrial respiratory
chain complex 1. Cell Transplant. 2007;16:409–19.
33. Eroglu A, Russo MJ, Bieganski R, Fowler A, Cheley S, Bayley H, et al.
Intracellular trehalose improves the survival of cryopreserved mammalian
cells. Nat Biotechnol. 2000;18:163–7.
34. Miyamoto Y, Suzuki S, Nomura K, Enosawa S. Improvement of hepatocyte
viability after cryopreservation by supplementation of long-chain
oligosaccharide in the freezing medium in rats and humans. Cell Transplant.
2006;15:911–9.
35. Miyamoto Y, Teramoto N, Hayashi S, Enosawa S. An improvement in the
attaching capability of cryopreserved human hepatocytes by a proteinaceous
high molecule, sericin, in the serum-free solution. Cell Transplant. 2010;19:701–6.
36. Unger C, Skottman H, Blomberg P, Sirac dilber M, Hovatta O. Good
manufacturing practice and clinical-grade human embryonic stem cell lines.
Hum Mol Genet. 2008;17:R48–53.
37. Holm F, Ström S, Inzunza J, Baker D, Strömberg A-M, Rozell B, et al. An effective
serum- and xeno-free chemically defined freezing procedure for human
embryonic and induced pluripotent stem cells. Hum Reprod. 2010;25:1271–9.
38. Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, et al. A
novel efficient feeder-free culture system for the derivation of human
induced pluripotent stem cells. Sci Rep. 2014;4:3594.
39. Yoshitaka M, Koichi O, Hiroshi Y, Hirofumi N, Masahiro S, Hisashi I, et al.
Cryopreservation of Human Adipose Tissue-Derived Stem/Progenitor Cells.
Cryobiol Cryotechnol. 2010;56:55–8.
40. Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, et al.
Improved cryopreservation of human hepatocytes using a new xeno free
cryoprotectant solution. World J Hepatol. 2012;4:176–83.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Miki et al. Stem Cell Research & Therapy  (2016) 7:8 Page 10 of 10
